Skip to content

EpiMend: The Next Generation of Interstitial Cystitis Treatments

A novel solution based treatment to restore sGAG and GAG associated pathways resulting in a more effective treatment

Published: 17th August 2021
EpiMend: The Next Generation of Interstitial Cystitis Treatments
SciePro, stock.adobe.com
Patents
  • US2020069725A1
  • EP3522901A2
  • JP2019534256A
IP Status
  • Patent application submitted
Seeking
  • Development partner
  • Commercial partner
  • Licensing